Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes
<p>Abstract</p> <p>Background</p> <p>Treatment guidelines recommend LDL-C as the primary target of therapy in patients with hypercholesterolemia. Moreover, combination therapies with lipid-lowering drugs that have different mechanisms of action are recommended when it i...
| Príomhchruthaitheoirí: | , , , , |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
BMC
2010-07-01
|
| Sraith: | Lipids in Health and Disease |
| Rochtain ar líne: | http://www.lipidworld.com/content/9/1/80 |